Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

CorMedix (CRMD) Income from Continuing Operations (2016 - 2025)

CorMedix (CRMD) has disclosed Income from Continuing Operations for 14 consecutive years, with 14020141.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations fell 56.9% to 14020141.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 163055000.0 through Dec 2025, up 14253.43% year-over-year, with the annual reading at 163055000.0 for FY2025, 14253.43% up from the prior year.
  • Income from Continuing Operations hit 14020141.0 in Q4 2025 for CorMedix, down from 108562980.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 108562980.0 in Q3 2025 to a low of 14466123.0 in Q1 2024.
  • Historically, Income from Continuing Operations has averaged 3833305.37 across 5 years, with a median of 7212027.0 in 2021.
  • Biggest five-year swings in Income from Continuing Operations: tumbled 64.15% in 2022 and later soared 4009.63% in 2025.
  • Year by year, Income from Continuing Operations stood at 9667173.0 in 2021, then grew by 15.08% to 8208951.0 in 2022, then decreased by 18.7% to 9744354.0 in 2023, then skyrocketed by 433.84% to 32530424.0 in 2024, then crashed by 56.9% to 14020141.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for CRMD at 14020141.0 in Q4 2025, 108562980.0 in Q3 2025, and 19827981.0 in Q2 2025.